Biomechanical, Microstructural and Material Properties of Tendon and Bone in the Young Oim Mice Model of Osteogenesis Imperfecta.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 Sep 2022
Historique:
received: 14 07 2022
revised: 18 08 2022
accepted: 24 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

Osteogenesis imperfecta (OI) is a genetic disorder of connective tissue characterized by low bone mass and spontaneous fractures, as well as extra-skeletal manifestations, such as dental abnormalities, blue sclera, hearing loss and joint hypermobility. Tendon ruptures have been reported in OI patients. Here, we characterized the biomechanical, structural and tissue material properties of bone and tendon in 5-week-old female osteogenesis imperfecta mice (oim), a validated model of severe type III OI, and compared these data with age- and sex-matched WT littermates. Oim tendons were less rigid and less resistant than those of WT mice. They also presented a significantly higher rate of pentosidine, without significant modification of enzymatic crosslinking. The oim bones were less resistant and avulsion fractures were evident at high tendinous stress areas. Alterations of trabecular and cortical bone microarchitectures were noticed in young female oim. Bone tissue material properties were also modified, with a less mature and more mineralized matrix in association with lower collagen maturity. Our data suggest that the tendon-to-bone unit is affected in young oim mice, which could explain tendon ruptures and bone fragility observed in OI patients.

Identifiants

pubmed: 36077325
pii: ijms23179928
doi: 10.3390/ijms23179928
pmc: PMC9456454
pii:
doi:

Substances chimiques

Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : SATT Ouest Valorisation
ID : #DV2541

Références

Calcif Tissue Int. 2020 Sep;107(3):281-293
pubmed: 32642787
Am J Physiol Cell Physiol. 2010 Jan;298(1):C149-62
pubmed: 19846750
Injury. 2017 Nov;48(11):2515-2521
pubmed: 28888715
J Bone Miner Res. 2020 Jul;35(7):1363-1374
pubmed: 32155286
Front Genet. 2021 Aug 10;12:705505
pubmed: 34447412
Dent J (Basel). 2021 Apr 27;9(5):
pubmed: 33925433
Bone. 2014 Oct;67:228-36
pubmed: 25065717
Metabolism. 2018 Mar;80:27-37
pubmed: 28625337
Matrix Biol. 2005 Oct;24(7):451-8
pubmed: 16095890
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103(3):314-20
pubmed: 17223585
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
Bone. 2012 Jun;50(6):1317-23
pubmed: 22449447
J Mech Behav Biomed Mater. 2019 Oct;98:20-25
pubmed: 31176091
Curr Osteoporos Rep. 2020 Aug;18(4):337-343
pubmed: 32710427
Osteoporos Int. 2010 Feb;21(2):195-214
pubmed: 19760059
Am J Med Genet A. 2014 Jun;164A(6):1470-81
pubmed: 24715559
Bone. 2015 Dec;81:315-326
pubmed: 26211992
J Bone Miner Res. 1999 Feb;14(2):264-72
pubmed: 9933481
Knee Surg Sports Traumatol Arthrosc. 2012 Feb;20(2):327-30
pubmed: 21717214
Muscles Ligaments Tendons J. 2014 Nov 17;4(3):333-42
pubmed: 25489552
Jpn Dent Sci Rev. 2016 Nov;52(4):84-92
pubmed: 28408960
Calcif Tissue Int. 1998 Feb;62(2):172-6
pubmed: 9437052
J Clin Orthop Trauma. 2020 Mar-Apr;11(2):339-343
pubmed: 32099308
Calcif Tissue Int. 2020 May;106(5):494-508
pubmed: 32025752
Anal Bioanal Chem. 2009 Oct;395(3):829-37
pubmed: 19685340
Bone. 2001 Nov;29(5):453-7
pubmed: 11704498
Elife. 2021 May 26;10:
pubmed: 34036937
Lancet. 1978 May 13;1(8072):1041-2
pubmed: 76956
Biomaterials. 2016 Nov;107:15-22
pubmed: 27589372
Cochrane Database Syst Rev. 2016 Oct 19;10:CD005088
pubmed: 27760454
J Bone Miner Res. 2014 Jun;29(6):1392-1401
pubmed: 24420672
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6 Suppl. 3):1-10
pubmed: 33386051
Curr Osteoporos Rep. 2016 Feb;14(1):1-9
pubmed: 26861807
Cureus. 2021 Jun 5;13(6):e15466
pubmed: 34258126
Lancet. 2004 Apr 24;363(9418):1377-85
pubmed: 15110498

Auteurs

Antoine Chretien (A)

Pole of Morphology, Institute of Experimental and Clinical Research (IREC), UCLouvain, 1200 Brussels, Belgium.

Malory Couchot (M)

Univ Angers, Nantes Université, Oniris, Inserm, RMeS, REGOS, SFR ICAT, F-49000 Angers, France.

Guillaume Mabilleau (G)

Univ Angers, Nantes Université, Oniris, Inserm, RMeS, REGOS, SFR ICAT, F-49000 Angers, France.
Department of Cell and Tissue Pathology, CHU Angers, F-49933 Angers, France.

Catherine Behets (C)

Pole of Morphology, Institute of Experimental and Clinical Research (IREC), UCLouvain, 1200 Brussels, Belgium.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH